Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.52 |
| ▸ | GHSR | Q92847 | 4/20 | 0.52 |
| ▸ | CTSL | P07711 | 3/20 | 0.52 |
| ▸ | CTSS | P25774 | 3/20 | 0.52 |
| ▸ | CTSK | P43235 | 3/20 | 0.52 |
| ▸ | CTSH | P09668 | 1/20 | 0.52 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.51 |
| ▸ | CCKBR | P32239 | 3/20 | 0.51 |
| ▸ | NPY1R | P25929 | 3/20 | 0.50 |
| ▸ | NPY2R | P49146 | 3/20 | 0.50 |
| ▸ | NPY4R | P50391 | 3/20 | 0.50 |
| ▸ | MC4R | P32245 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30464993 | 0.95 | IL23R (0.58) | IL23RCTSLCTSSCTSKCTSH | |
| SCHEMBL30464981 | 0.93 | IL23R (0.60) | IL23RGHSRCTSLCTSSCTSK | |
| SCHEMBL30465002 | 0.93 | IL23R (0.60) | IL23RGHSRCTSLCTSSCTSK | |
| SCHEMBL30464997 | 0.92 | IL23R (0.57) | IL23RCTSLCTSSCTSKCTSH | |
| SCHEMBL29973131 | 0.91 | C5AR1 (0.55) | IL23RGHSRC5AR1CCKBRNPY2R | |
| SCHEMBL29384877 | 0.91 | C5AR1 (0.55) | IL23RGHSRC5AR1CCKBRNPY2R | |
| SCHEMBL30464982 | 0.91 | IL23R (0.59) | IL23RGHSRCTSLCTSSCTSK | |
| SCHEMBL29973259 | 0.90 | GLP1R (0.52) | IL23RCTSLCTSSCTSKCTSH | |
| SCHEMBL29814670 | 0.89 | IL23R (0.61) | IL23RGHSRCCKBRMC4R | |
| SCHEMBL1370998 | 0.89 | IL23R (0.65) | IL23RCTSLCTSSCTSKCTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3030256-B1 | NDP-MSH FOR USE IN THE TREATMENT OF MULTIPLE SCLEROSIS | CLINUVEL PHARMACEUTICALS LTD (AU) | 2024-01-24 | — | — | EP | disclosed |